RightFit Trial Directory

Crohn's Disease clinical trials in Houston, TX

20 recruiting crohn's disease studies with a site in Houston, TX.

All trials in Houston, TX · All Crohn's Disease trials

RecruitingPhase 3NCT06819878

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Hoffmann-La Roche

Arlington, TX · El Paso, TX · Georgetown, TX · +92 more sites

RecruitingPhase 2NCT07697456

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Sponsor: AbbVie

Bellaire, TX · Fort Worth, TX · Garland, TX · +57 more sites

RecruitingPhase 4NCT06581328

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Sponsor: Takeda

El Paso, TX · Georgetown, TX · Houston, TX · +98 more sites

RecruitingPhase 3NCT06430801

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Sponsor: Merck Sharp & Dohme LLC

Dallas, TX · Denton, TX · +84 more sites

RecruitingPhase 2NCT06226883

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

Cedar Park, TX · Denton, TX · Houston, TX · +22 more sites

RecruitingPhase 1NCT03816345

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Sponsor: National Cancer Institute (NCI)

Dallas, TX · Fort Worth, TX · +48 more sites

RecruitingPhase 3NCT06819891

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Hoffmann-La Roche

Dallas, TX · Fort Worth, TX · Garland, TX · +58 more sites

RecruitingPhase 2NCT06548542

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Sponsor: AbbVie

Cedar Park, TX · El Paso, TX · Garland, TX · +61 more sites

RecruitingPhase 2 / Phase 3NCT07196722

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Janssen Research & Development, LLC

Austin, TX · Carrollton, TX · Dallas, TX · +58 more sites

RecruitingPhase 4NCT06045754

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Sponsor: Takeda

Cedar Park, TX · Dallas, TX · Houston, TX · +38 more sites

RecruitingPhase not listedNCT04372108

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

Sponsor: Janssen Scientific Affairs, LLC

Houston, TX

RecruitingNot applicableNCT05230173

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Sponsor: Mayo Clinic

Dallas, TX · Houston, TX · +22 more sites

RecruitingPhase not listedNCT04751396

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingNot applicableNCT03256240

Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

Sponsor: Weill Medical College of Cornell University

Dallas, TX · Houston, TX · +4 more sites

RecruitingPhase 3NCT05442567

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Sponsor: Takeda

Houston, TX · +21 more sites

RecruitingPhase 3NCT04779320

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Sponsor: Takeda

Houston, TX · +21 more sites

RecruitingPhase 2NCT06456593

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Sponsor: Abivax S.A.

Austin, TX · Baytown, TX · Bellaire, TX · +40 more sites

RecruitingPhase 2NCT07113522

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Sponsor: Mirador Therapeutics, Inc.

Dallas, TX · Garland, TX · Georgetown, TX · +43 more sites

RecruitingPhase 4NCT06257706

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Sponsor: Alimentiv Inc.

Houston, TX · +2 more sites

Not yet recruitingNot applicableNCT07397195

ACT for Veterans With IBD and Mental Health Challenges

Sponsor: VA Office of Research and Development

Houston, TX

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.